Frontlight ResearchEarly access
Taking people in United StatesNo phase
Assessing Immune Dysfunction in Sepsis
Key facts
- Who runs it
- University of Minnesota
- Where
- Minneapolis, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 1 Mar 2026
- Expected to end
- 1 Nov 2028
- Type of study
- Observational, 3 groups
- Treatments tested
- Observational Only
- Record updated
- 23 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who cannot take part
- Medication usage that includes immunosuppressive drugs, biologic agents, cytokines, growth factor and interleukins
- Steroid medication usage of \> 300mg hydrocortisone per day (equivalent of \> 20mg prednisone). Patients with chronic steroid use will be excluded, however patients who have had stress dose steroids administered following admission will be included
- Known history of chronic hepatitis B (HBV) infection and not on treatment with HBV nucleoside analogues prior to the current hospitalization, or HBV DNA \> 100 IU/mL
- Participation in another investigational interventional drug study within the past 4 weeks
- Active cancer with chemotherapy and/or radiation treatment within the past 6 weeks
- Patients with a history of, or who currently have evidence of autoimmune disease, including but not limited to: myasthenia gravis, Guillain Barré syndrome, systemic lupus erythematosus, multiple sclerosis, scleroderma, ulcerative colitis, Crohn's disease, autoimmune hepatitis, Wegener's granulomatosis, HIV/AIDS, etc
- Patients with active or a history of acute or chronic lymphocytic leukemia
- Known history of infection with hepatitis C (HCV) and currently undergoing treatment for HCV infection or has detectable HCV RNA
- Current pregnancy
- Current incarceration
Other criteria
- ICU With Sepsis Inclusion Criteria:
- Age ≥ 18
- Presumed diagnosis of sepsis, defined as "patients with life-threatening organ dysfunction caused by a dysregulated host response to infection"
- Patients in the ICU who meet 2 or more of the quick SOFA (qSOFA) definition along with organ dysfunction:; Respiration rate ≥ 22 breaths/min and/or mechanically ventilated; An alteration in mental status; Systolic blood pressure of less than 100 mm Hg and/or receiving inotropes to maintain blood pressure AND/OR; <!-- -->; An acute change in SOFA score ≥2 points, consequent to the infection (can assume SOFA score = 0 in patients with no pre-existing organ dysfunction); ICU Without Sepsis Inclusion Criteria:
- Age ≥ 18
- Patients requiring care at a M Health Fairview ICU due to high acuity of illness and no other evidence of sepsis; Healthy Volunteer Inclusion Criteria
- Age greater or equal to 18
- ASA status 1, 2 or 3
- May include patients who are receiving dialysis in an outpatient setting
Where in United States
- University of MinnesotaMinneapolis, United StatesContact: Kristine KancansTaking people
About the trial
What the trial wants to find out
Sepsis leads to sustained immune system dysfunction resulting in increased susceptibility to secondary infection while in the hospital or after discharge. Consequently, many of the ~2 million Americans that develop sepsis every year will end up back in the ICU, weeks and months later. The objective of this study is to define the cellular and molecular mechanisms driving the dysfunction and reprogramming of T cells and B cells that mediate cellular and humoral immunity using a combination of phenotypic, functional, genomic, and metabolomic assays.
The 3 groups in the trial
- ICU Patients with Sepsis
Treatment: Observational Only
- ICU Patients without Sepsis
Treatment: Observational Only
- Healthy Volunteers
Treatment: Observational Only
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 23 September 2026